Register
Medicines reference
Product

Glumax

Dexpanthenol · NTC S.r.l.

1 form: gel. Not applicable (not a medicine).

Forms and dosesNot applicable (not a medicine)

Form Dose Frequency Georgia
Gel No label dose in the reference yet - Georgia Not a medicine
Not applicable (not a medicine)
In the register: გლუმაქსი 5% 10გ თვ/გელი
Verified on: 22 Oct 2026
Details: pack, label wording, sources, registration

Glumax, Gel

dexpanthenol 50 mg/g (5%), ophthalmic gel, medical device (human)
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Potential supportive ocular-surface lubrication with exact Glumax dexpanthenol 5% + carbomer gel in a dog or cat after diagnosis of dry-eye, exposure-related or epithelial disease
Not rateable
No numerical score assigned
vetman assessment

Glumax

dexpanthenol 50 mg/g (5%), ophthalmic gel, medical device (human)
Assessed clinical scopeDog · Potential supportive ocular-surface lubrication with exact Glumax dexpanthenol 5% + carbomer gel in a dog or cat after diagnosis of dry-eye, exposure-related or epithelial disease · Into the eye
Care settingVeterinarian-directed adjunctive use only after a complete ophthalmic examination and without replacing disease-modifying, anti-infective or surgical care
vetman score Not rateable No numerical score assigned
Evidence confidence: Medium Georgia: Not a medicine · Verified on 22 Oct 2026 Off-label use
Not rateable

A numerical product score cannot responsibly be assigned. Glumax has a verifiable 5% dexpanthenol/carbomer human-device identity and a plausible lubricant rationale, but no exact-product canine dose, ocular PK, repeated-dose tolerance or clinical outcome study was found. Canine studies of other carbomer and lubricant formulations show that vehicles differ in comfort and retention and cannot establish this preserved gel’s efficacy, safety or regimen.

Glumax is correctly treated as a human ophthalmic medical device, not a medicine. Lubrication and dexpanthenol biology are plausible, but indirect human, laboratory and other-formulation evidence does not create an exact-product veterinary score or dose.

Important safety and use flags

  • No exact-product dog/cat efficacy, ocular PK, repeated-dose target-animal safety or dose study was found. Do not convert human, in-vitro or other-lubricant evidence into a veterinary product score.
  • Glumax is a CE-marked human ophthalmic medical device, not a registered medicinal product. Its correct market status is “registration not applicable”; this category does not imply veterinary authorisation or proven veterinary benefit.
  • Use only as supportive lubrication after diagnosis. It is not antibacterial, antiviral, antifungal, anti-inflammatory or tear-stimulating and must not replace condition-specific treatment.
  • Pain, blepharospasm, persistent redness or discharge, corneal opacity/ulceration, trauma or vision change requires prompt complete ophthalmic examination rather than empirical lubricant-only care.
  • The exact multidose gel is preserved with cetrimide, but its concentration and repeated dog/cat tolerance are not established here. Stop and reassess if irritation or ocular-surface worsening occurs; in-vitro cetrimide findings from another formulation are a caution, not proof of Glumax toxicity.
  • Do not copy human use directions or another carbomer, dexpanthenol or lubricant regimen. No diagnosis-independent dog/cat frequency, course or amount is published here.
  • Canine carbomer comparisons and feline peri-anaesthetic lubricant studies used different products and settings. Their comfort, retention and outcome data cannot be assigned to Glumax.
  • Avoid tube-tip contact with the eye, lashes, skin or fingers and do not share a tube between patients. Separate other ophthalmic products by at least 15 minutes unless a veterinary ophthalmologist directs otherwise.
  • The human product information says to use the tube within eight weeks after opening. Follow the exact pack’s storage instructions and discard sooner if contamination, damage or an altered appearance is suspected.
  • Safety in pregnant, lactating, breeding or juvenile dogs and cats is not established. Use only after a patient-specific veterinary benefit-risk decision.
Assessment sources
Assessed: 22 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Cat Potential supportive ocular-surface lubrication with exact Glumax dexpanthenol 5% + carbomer gel in a dog or cat after diagnosis of dry-eye, exposure-related or epithelial disease
Not rateable
No numerical score assigned
vetman assessment

Glumax

dexpanthenol 50 mg/g (5%), ophthalmic gel, medical device (human)
Assessed clinical scopeCat · Potential supportive ocular-surface lubrication with exact Glumax dexpanthenol 5% + carbomer gel in a dog or cat after diagnosis of dry-eye, exposure-related or epithelial disease · Into the eye
Care settingVeterinarian-directed adjunctive use only after a complete ophthalmic examination and without replacing disease-modifying, anti-infective or surgical care
vetman score Not rateable No numerical score assigned
Evidence confidence: Medium Georgia: Not a medicine · Verified on 22 Oct 2026 Off-label use
Not rateable

A numerical product score cannot responsibly be assigned. Glumax has a verifiable 5% dexpanthenol/carbomer human-device identity and a plausible lubricant rationale, but no exact-product feline dose, ocular PK, repeated-dose tolerance or clinical outcome study was found. Short peri-anaesthetic use of a different feline eye gel and a small heterogeneous feline dry-eye case series cannot establish this preserved gel’s chronic efficacy, safety or regimen.

Glumax is correctly treated as a human ophthalmic medical device, not a medicine. Lubrication and dexpanthenol biology are plausible, but indirect human, laboratory and other-formulation evidence does not create an exact-product veterinary score or dose.

Important safety and use flags

  • No exact-product dog/cat efficacy, ocular PK, repeated-dose target-animal safety or dose study was found. Do not convert human, in-vitro or other-lubricant evidence into a veterinary product score.
  • Glumax is a CE-marked human ophthalmic medical device, not a registered medicinal product. Its correct market status is “registration not applicable”; this category does not imply veterinary authorisation or proven veterinary benefit.
  • Use only as supportive lubrication after diagnosis. It is not antibacterial, antiviral, antifungal, anti-inflammatory or tear-stimulating and must not replace condition-specific treatment.
  • Pain, blepharospasm, persistent redness or discharge, corneal opacity/ulceration, trauma or vision change requires prompt complete ophthalmic examination rather than empirical lubricant-only care.
  • The exact multidose gel is preserved with cetrimide, but its concentration and repeated dog/cat tolerance are not established here. Stop and reassess if irritation or ocular-surface worsening occurs; in-vitro cetrimide findings from another formulation are a caution, not proof of Glumax toxicity.
  • Do not copy human use directions or another carbomer, dexpanthenol or lubricant regimen. No diagnosis-independent dog/cat frequency, course or amount is published here.
  • Canine carbomer comparisons and feline peri-anaesthetic lubricant studies used different products and settings. Their comfort, retention and outcome data cannot be assigned to Glumax.
  • Avoid tube-tip contact with the eye, lashes, skin or fingers and do not share a tube between patients. Separate other ophthalmic products by at least 15 minutes unless a veterinary ophthalmologist directs otherwise.
  • The human product information says to use the tube within eight weeks after opening. Follow the exact pack’s storage instructions and discard sooner if contamination, damage or an altered appearance is suspected.
  • Safety in pregnant, lactating, breeding or juvenile dogs and cats is not established. Use only after a patient-specific veterinary benefit-risk decision.
Assessment sources
Assessed: 22 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Composition / strength
Dexpanthenol50 mg/g
Formulation Type
Gel
Administration route
Into the eye
Manufacturer
NTC S.r.l. · Italy
Registration
Georgia Not a medicine
Not applicable (not a medicine)
In the register: გლუმაქსი 5% 10გ თვ/გელი
Verified on: 22 Oct 2026
EU Not a medicine
Not applicable (not a medicine)
Verified on: 15 Oct 2026
UK Not a medicine
Not applicable (not a medicine)
Verified on: 15 Oct 2026
US Not a medicine
Not applicable (not a medicine)
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Information not fully verified No dog/cat dose, treatment frequency or veterinary indication is established for this exact product. It is a CE-marked human ophthalmic medical device for lubrication/ocular-surface support, not an authorised veterinary medicine. Do not copy its human instructions or regimens from other carbomer, lubricant or dexpanthenol products.

Dexpanthenol: No dose supported by a publicly verifiable source yet

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.